Regulations.gov document
Tissue Agnostic Therapies in Oncology: Regulatory Considerations for Orphan Drug…
Notice · FDA-2018-N-0663 · posted Feb 27, 2018
Key facts
| Document ID | FDA-2018-N-0663-0001 |
|---|---|
| Title | Tissue Agnostic Therapies in Oncology: Regulatory Considerations for Orphan Drug Designation; Public Workshop; Request for Comments |
| Document type | Notice |
| Subtype | Announcement |
| Agency | FDA |
| Docket | FDA-2018-N-0663 |
| Posted | Feb 27, 2018 |
| Federal Register citation | 83 FR 8485 |
| FR document number | 2018-03961 |
| Comment period opens | Feb 27, 2018 |
| Comments due | Jun 9, 2018 |
| Effective date | Feb 27, 2018 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: